Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice

Journal of Laboratory and Clinical Medicine

Volumn 146, Issue 5, 2005, Pages 299-303

  Hou, Guoqing ^a   Dick, Robert ^a   Abrams, Gerald D ^a   Brewer, George J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; CREATINE KINASE; CYTOKINE; DOXORUBICIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; LACTATE DEHYDROGENASE; TETRATHIOMOLYBDIC ACID; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE MARKER; DISEASE MODEL; DRUG MECHANISM; HEART INJURY; HEART PROTECTION; HEMATOLOGICAL PARAMETERS; INFLAMMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; T LYMPHOCYTE ACTIVATION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARDIOMYOPATHIES; CHELATING AGENTS; CREATINE KINASE; DISEASE MODELS, ANIMAL; DOXORUBICIN; DRUG THERAPY, COMBINATION; INTERLEUKIN-1; INTERLEUKIN-2; L-LACTATE DEHYDROGENASE; MALE; MICE; MICE, INBRED C57BL; MOLYBDENUM; TROPONIN I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26844452252     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2005.07.004     Document Type: Article

References (24)

1. D.D. Von Hoff, M.W. Layard, P. Basa, H.L.J. Davis, A.L. Von Hoff, M. Rozencweig Risk factors for doxorubicin-induced congestive heart failure Ann Intern Med 91 1979 710 717
2. A.U. Buzdar, C. Marcus, T.L. Smith, G.R. Blumenschein Early and delayed clinical cardiotoxicity of doxorubicin Cancer 55 1985 2761 2765
3. V.J. Ferrans Overview of cardiac pathology in relation to anthracycline cardiotoxicity Cancer Treat Rep 62 1978 955 961
4. P.K. Singal, C.M. Deally, L.E. Weinberg Subcellular effects of adriamycin in the heart a concise review J Mol Cell Cardiol 19 1987 817 828
5. C. Myers The role of iron in doxorubicin-induced cardiomyopathy Semin Oncol 25 4 suppl 10 1998 10 14
6. S.Y. Saad, T.A. Najjar, A.C. Al-Rikabi The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats Pharmacol Res 43 2001 211 218
7. G.J. Brewer, M.R. Ullenbruch, R.B. Dick, L. Olivarez, S.H. Phan Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice J Lab Clin Med 141 2003 210 216
8. G.J. Brewer, R. Dick, M.R. Ullenbruch, H. Jin, S.H. Phan Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis J Inorg Biochem 98 2004 2160 2167
9. F.K. Askari, R.B. Dick, M. Mao, G.J. Brewer Tetrathiomolybdate therapy protects against concanavalin A and carbon tetrachloride hepatic damage in mice Exp Biol Med 229 2004 857 863
10. S. Ma, G. Hou, R.D. Dick, G.J. Brewer Tetrathiomolybdate protects against liver injury from acetaminophen in mice J Appl Res Clin Exp Ther 4 2004 419 426
11. G.J. Brewer, P. Hedera, K.J. Kluin, M. Carlson, F. Askari, R.B. Dick Treatment of Wilson disease with ammonium tetrathiomolybdate. III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy Arch Neurol 60 2003 379 385
12. Q. Pan, L.W. Bao, C.G. Kleer, G.J. Brewer, S.D. Merajver Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma Mol Cancer Ther 2 2003 617 622
13. K.H. Schosinsky, H.P. Lehmann, M.F. Beeler Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride Clin Chem 20 1974 1556 1563
14. H.C. Yen, T.D. Oberley, S. Vichitbandha, Y.S. Ho, D.K. St. Clair The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice J Clin Invest 98 1996 1253 1260
15. G.J. Brewer, R.D. Dick, D.K. Grover, V. LeClaire, M. Tseng, M. Wicha Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent phase I study Clin Cancer Res 6 2000 1 10
16. B.G. Redman, P. Esper, Q. Pan, R.L. Dunn, H.K. Hussain, T. Chenevert Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer Clin Cancer Res 9 2003 1666 1672
17. M.J. Elliott, R.N. Maini, M. Feldmann, A. Long-Fox, P. Charles, P. Katsikis Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha Arthritis Rheum 36 1993 1681 1690
18. J.C. Shanahan, W. St. Clair Tumor necrosis factor-alpha blockade a novel therapy for rheumatic disease Clin Immunol 103 3 Pt 1 2002 231 242
19. G. D'Haens, S. Van Deventer, R. Van Hogezand, D. Chalmers, C. Kothe, F. Baert Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease a European multicenter trial Gastroenterology 116 1999 1029 1034
20. P.J. Mease, B.S. Goffe, J. Metz, A. VanderStoep, B. Finck, D.J. Burge Etanercept in the treatment of psoriatic arthritis and psoriasis a randomised trial Lancet 356 2000 385 390
21. S. Lebecque A new job for dendritic cells Nat Immunol 2 2001 830 831
22. Q. Pan, C.G. Kleer, K.L. van Golen, J. Irani, K.M. Bottema, C. Bias Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis Cancer Res 62 2002 4854 4859
23. Q. Pan, L.W. Bao, S.D. Merajver Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappaB signaling cascade Mol Cancer Res 1 2003 701 706
24. H.C. Morse, J.B. Roths, W.F. Davidson, W.Y. Langdon, T.N. Fredrickson, J.W. Hartley Abnormalities induced by the mutant gene, lpr. Patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr J Exp Med 161 1985 602 616